FindTrial
Sign In

therapeutic procedure

PROCEDURE5 trials

Sponsors

Favrille, Yale University, Fox Chase Cancer Center, Stanford University

Conditions

LymphomaMalignant NeoplasmMalignant Pericardial EffusionMalignant Pleural EffusionRecurrent MelanomaRecurrent Non-small Cell Lung CancerStage 0 Nasopharyngeal CarcinomaStage 0 Paranasal Sinus Cancer

Phase 2

Molecularly Targeted Therapy in Treating Patients With BRAF Wild-type Melanoma That is Metastatic
CompletedNCT02094872
Yale UniversityRecurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma +2
Start: 2014-05-31End: 2018-12-31Updated: 2020-01-02

Phase 3

GM-CSF With or Without Vaccine Therapy After Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
SuspendedNCT00324831
FavrilleLymphoma
Target: 480Updated: 2013-12-18

Unknown Phase

Next Generation Sequence Target-Directed Therapy in Treating Patients With Cancer
CompletedNCT02132845
Fox Chase Cancer CenterMalignant Neoplasm
Start: 2016-03-17End: 2018-05-10Updated: 2021-02-04
Genetic Sequencing-Informed Targeted Therapy in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
TerminatedNCT02132884
Fox Chase Cancer CenterMalignant Pericardial Effusion, Malignant Pleural Effusion, Recurrent Non-small Cell Lung Cancer +2
Start: 2015-03-31End: 2016-08-31Updated: 2019-09-04
Olfactory Training in Improving Sense of Smell After Radiation Therapy in Patients With Paranasal Sinus or Nasopharyngeal Cancer
TerminatedNCT03049358
Stanford UniversityStage 0 Nasopharyngeal Carcinoma, Stage 0 Paranasal Sinus Cancer, Stage IIA Nasopharyngeal Carcinoma +15
Start: 2016-12-31End: 2018-10-31Updated: 2019-02-05